Jacobs Levy Equity Management
CGNT

Jacobs Levy Equity Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Jacobs Levy Equity Management’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,400
Closed -$26K – 1077
2017
Q1 		$26K Buy
+14,400
New +$28.5K ﹤0.01% 903

Other funds holding CGNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's CGNT Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2017, closing a stake of 14,400 shares — an estimated $26K sold.

Jacobs Levy Equity Management first reported a position in CGNT in Q1 2017 and held it in 1 quarter. The position peaked at $26K in Q1 2017. 34 funds tracked by Wall St. Rank hold CGNT as of Q2 2017.

  • Jacobs Levy Equity Management reported no remaining Cogentix Medical, Inc. position as of Q2 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 14,400 Cogentix Medical, Inc. shares in Q2 2017, an estimated $26K.
  • Jacobs Levy Equity Management first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Cogentix Medical, Inc. position peaked at $26K in Q1 2017.
  • 34 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.